[2] As of 31 march 2024, the group treated 112 008 patients for a total of 446 623 inpatient days.

Hirslanden thus became a wholly owned subsidiary of Mediclinic International, a public limited company listed on the London Stock Exchange (LSE).

In 2023, Mediclinic International was acquired by Remgro Limited and SAS (part of MSC).

In the course of the takeover, the company was delisted from the stock exchange and renamed the Mediclinic Group.

[3] In May of the same year, the subsidiary Hirslanden Venture Capital was founded at the headquarters in Opfikon, which, according to the commercial register, is intended to invest in particular in start-ups with innovative technologies and new business models.